Literature DB >> 18160840

The association of Pro12Ala polymorphism of peroxisome proliferator-activated receptor-gamma gene with serum osteoprotegerin levels in healthy Korean women.

Eun-Jung Rhee1, Ki-Won Oh, Eun-Joo Yun, Chan-Hee Jung, Cheol-Young Park, Won-Young Lee, Eun-Sook Oh, Ki-Hyun Baek, Moo-Il Kang, Sung-Woo Park, Sun-Woo Kim.   

Abstract

Recent evidences suggest that the activation of peroxisome proliferator-activated receptor (PPAR)-gamma, which is an important transcriptional factor in adipocyte differentiation, also plays an important role in the bone microenvironment. The objective of the study was to clarify whether Pro12Ala polymorphism was related to the serum OPG levels and bone mineral metabolism in healthy Korean women. In 239 Korean women (mean age 51 years), who participated in medical check-up program in a health promotion center, anthropometric measurements, lumbar spine and femoral neck bone mineral density (BMD), bone turnover markers, such as serum total alkaline phosphatase (ALP) levels, urine deoxypyridinoline levels, and 24-h urine calcium excretion were measured. Serum levels of OPG were measured with ELISA method. DNAs were extracted from the samples and the genotyping of the Pro12Ala polymorphism (rs1801282) in the PPAR-gamma gene was performed via an allelic discrimination assay using a TaqMan probe. In addition, we examined the haplotype analysis between two polymorphisms of PPAR-gamma gene, Pro12Ala in exon B and C161T in exon 6 (rs3856806). Allelic frequencies were 0.950 for Pro allele and 0.050 for Ala allele, which was in compliance with Hardy- Weinberg equilibrium, and there was no Ala12Ala genotype among the genotyped subjects. Mean serum OPG level was significantly lower (P=0.035), and serum total ALP was significantly higher (P=0.014) in the Pro12Ala genotype group compared with the Pro12Pro genotype group, which were consistently significant even after adjustment for weight, height, and serum follicle stimulating hormone (FSH). In multiple regression analysis with serum OPG as the dependent variable and age, weight, ALP, femoral neck BMD and Pro12Ala genotype included in the model, only Pro12Ala genotype was significant determinant of serum OPG level (b=??0.136, P=0.035). The haplotype analysis with C161T polymorphism revealed that subjects with Ala and T alleles showed significantly lower serum OPG levels compared with those with Pro12Pro/CC genotype, which were consistently significant even after adjustment for age, weight, height and FSH (P=0.010). This result suggests statistically significant association of Pro12Ala polymorphisms with serum OPG levels in Korean females.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18160840     DOI: 10.1038/emm.2007.76

Source DB:  PubMed          Journal:  Exp Mol Med        ISSN: 1226-3613            Impact factor:   8.718


  8 in total

1.  No association between polymorphisms of peroxisome [corrected] proliferator-activated receptor-gamma gene and peak bone mineral density variation in Chinese nuclear families.

Authors:  H Yue; J-W He; H Zhang; W-W Hu; Y-Q Hu; M Li; Y-J Liu; S-H Wu; Z-L Zhang
Journal:  Osteoporos Int       Date:  2009-07-31       Impact factor: 4.507

Review 2.  Molecular genetic studies of gene identification for osteoporosis: the 2009 update.

Authors:  Xiang-Hong Xu; Shan-Shan Dong; Yan Guo; Tie-Lin Yang; Shu-Feng Lei; Christopher J Papasian; Ming Zhao; Hong-Wen Deng
Journal:  Endocr Rev       Date:  2010-03-31       Impact factor: 19.871

3.  Identification of pleiotropic genetic variants affecting osteoporosis risk in a Korean elderly cohort.

Authors:  Eun Pyo Hong; Ka Hyun Rhee; Dong Hyun Kim; Ji Wan Park
Journal:  J Bone Miner Metab       Date:  2017-12-22       Impact factor: 2.626

4.  Association of PPARgamma allelic variation, osteoprotegerin and abdominal aortic aneurysm.

Authors:  Corey S Moran; Paula Clancy; Erik Biros; Bernardo Blanco-Martin; Pamela McCaskie; Lyle J Palmer; Danny Coomans; Paul E Norman; Jonathan Golledge
Journal:  Clin Endocrinol (Oxf)       Date:  2009-04-25       Impact factor: 3.478

5.  β-catenin directly sequesters adipocytic and insulin sensitizing activities but not osteoblastic activity of PPARγ2 in marrow mesenchymal stem cells.

Authors:  Sima Rahman; Piotr J Czernik; Yalin Lu; Beata Lecka-Czernik
Journal:  PLoS One       Date:  2012-12-18       Impact factor: 3.240

6.  Changes in bone biological markers after treatment of Iranian diabetic patients with pioglitazone: No relation to polymorphism of PPAR-γ (Pro12Ala).

Authors:  Peyman Mottaghi
Journal:  J Res Med Sci       Date:  2013-04       Impact factor: 1.852

7.  Changes in bone biological markers after treatment of Iranian diabetic patients with pioglitazone: No relation to polymorphism of PPAR-γ (Pro12Ala).

Authors:  Fatemeh Namvaran; Parvaneh Rahimi-Moghaddam; Negar Azarpira; Mohammad Hossien Dabbaghmanesh; Marzieh Bakhshayeshkaram; Mohamad Mahdi Namvaran
Journal:  J Res Med Sci       Date:  2013-04       Impact factor: 1.852

8.  Common variants in FLNB/CRTAP, not ARHGEF3 at 3p, are associated with osteoporosis in southern Chinese women.

Authors:  G H Y Li; A W C Kung; Q-Y Huang
Journal:  Osteoporos Int       Date:  2009-09-01       Impact factor: 4.507

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.